RenaissanceRe stock is trading -20.39% below its average target price of $269.0 after dropping -3.2% during today's afternoon session. Analysts are giving the Large-Cap Property & Casualty Insurance company an average rating of buy and target prices ranging from $218.0 to $334.0 per share.
RenaissanceRe's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.1%. The stock's short ratio is 3.85. The company's insiders own 1.88% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 98.8%. In conclusion, we believe there is positive market sentiment regarding RenaissanceRe.
Institutions Invested in RenaissanceRe
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 10% | 5,497,818 | $1,177,302,743 |
| 2024-03-31 | Blackrock Inc. | 9% | 4,942,771 | $1,058,444,978 |
| 2024-03-31 | Bank Of New York Mellon Corporation | 5% | 2,752,016 | $589,316,704 |
| 2024-03-31 | Capital World Investors | 5% | 2,473,322 | $529,637,171 |
| 2024-03-31 | State Farm Mutual Automobile Insurance Co | 5% | 2,399,303 | $513,786,742 |
| 2024-03-31 | Orbis Allan Gray Ltd | 4% | 2,375,616 | $508,714,408 |
| 2024-03-31 | State Street Corporation | 4% | 2,329,575 | $498,855,189 |
| 2024-03-31 | Egerton Capital (UK) LLP | 4% | 1,858,824 | $398,048,570 |
| 2024-03-31 | Price (T.Rowe) Associates Inc | 3% | 1,751,933 | $375,158,931 |
| 2023-12-31 | Boston Partners | 3% | 1,431,954 | $306,638,628 |
